Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,496.00
(
0.41%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
107.07
(
-1.93%
)
Bitcoin
68,858.03
(
0.00%
)
News Focus
News Focus
Post# of 80490
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: biomaven0 post# 14278

Thursday, 11/17/2011 10:17:28 AM

Thursday, November 17, 2011 10:17:28 AM

Post# of 80490
In the Phase 1, do we know anything about the patients who responded very well (and are still taking P) on a dosing schedule of less than 30 mg/daily? I assume they were refractory to other TKIs (or T315i patients)....were any of these people NOT on any other TKI for an extended period of time?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today